Wungki Park
- Oncology top 1%
- Pancreatic and Hepatic Oncology Research 41
- Cancer Immunotherapy and Biomarkers 16
- Cancer Cells and Metastasis 6
- Peptidase Inhibition and Analysis 5
- Cancer Research top 2%
- Cancer Genomics and Diagnostics 29
- Molecular Medicine top 5%
-
- Renal cell carcinoma treatment 8
- Lung Cancer Treatments and Mutations 7
- Immunology top 10%
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 10
- Co-authors
- Eileen M. O’ReillyAkhil ChawlaDong M. ShinZhuo Georgia ChenA.R.M. Ruhul AminGilberto LopesVaia FlorouDeukwoo Kwon
- Journals
- JAMA (2 papers)Journal of Clinical Oncology (28 papers)SHILAP Revista de lepidopterología (1 paper)
- Partner nations
- United StatesJapanFrance
In The Last Decade
Wungki Park
69 papers receiving 2.6k citations
Hit Papers
Peers
Comparison fields: 5 of 102
- Oncology 1.7k
- Cancer Research 654
- Molecular Medicine 132
- Pulmonary and Respiratory Medicine 803
- Immunology 288
Countries citing papers authored by Wungki Park
This map shows the geographic impact of Wungki Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wungki Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wungki Park more than expected).
Fields of papers citing papers by Wungki Park
This network shows the impact of papers produced by Wungki Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wungki Park. The network helps show where Wungki Park may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wungki Park, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 5 | |
| 7 | 2024 | 2 | |
| 8 | 2024 | 2 | |
| 9 | 2024 | 12 | |
| 10 | 2024 | 0 | |
| 11 | 2023 | 14 | |
| 12 | 2023 | 9 | |
| 13 | 2023 | 1 | |
| 14 | 2023 | 1 | |
| 15 | 2022 | 7 | |
| 16 | 2022 | 7 | |
| 17 | 2022 | 13 | |
| 18 | 2020 | 49 | |
| 19 | 2020 | 66 | |
| 20 | 2017 | 29 |
About Wungki Park
Wungki Park is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 81 papers that have together received 2.7k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (41 papers), Cancer Genomics and Diagnostics (29 papers), Cancer Immunotherapy and Biomarkers (16 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers), Renal cell carcinoma treatment (8 papers), Lung Cancer Treatments and Mutations (7 papers), Cancer Cells and Metastasis (6 papers) and Peptidase Inhibition and Analysis (5 papers). The work is most often cited by research in Oncology (1.7k citations), Cancer Research (654 citations) and Molecular Medicine (132 citations). Wungki Park has collaborated with scholars based in United States, Japan and France. Frequent co-authors include Eileen M. O’Reilly, Akhil Chawla, Dong M. Shin, Zhuo Georgia Chen, A.R.M. Ruhul Amin, Gilberto Lopes, Vaia Florou, Deukwoo Kwon, Anna M. Varghese and Kenneth H. Yu. Their work appears in journals such as JAMA, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.